Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q4 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $1 thousand.

For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.

Earnings